CONBA(SH:600572) Shang Hai Zheng Quan Bao·2025-11-11 19:56Core Viewpoint - The announcement details the share reduction plan executed by Zhejiang Conba Pharmaceutical Co., Ltd. and its major shareholder, Conba Group, which successfully reduced its holdings by approximately 25.24 million shares, representing 1% of the company's total share capital [2][3][4]. Group 1: Shareholder Holding Information - Conba Group planned to reduce its holdings from 254,431,171 shares, which accounted for 10.079% of the total share capital of 2,524,267,371 shares as of August 14, 2025 [2]. - After the reduction, Conba Group and Hu Jiqiang hold a combined total of 323,188,576 shares, representing 12.792% of the current total share capital of 2,526,581,971 shares as of November 10, 2025 [3][4]. Group 2: Implementation of Reduction Plan - The share reduction took place from October 23 to November 11, 2025, with Conba Group successfully reducing its holdings by 25,242,600 shares, which is 1.000% of the total share capital at the time of the announcement [3][4]. - The reduction was completed as planned, with no deviations from the previously disclosed reduction plan [4]. Group 3: Upcoming Investor Communication - The company will hold a performance briefing on November 19, 2025, from 2:00 PM to 3:00 PM to discuss the third-quarter results and address investor inquiries [6][8]. - Investors can participate in the briefing through the Shanghai Stock Exchange Roadshow Center and submit questions in advance [10][11].